BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benmelouka AY, Munir M, Sayed A, Attia MS, Ali MM, Negida A, Alghamdi BS, Kamal MA, Barreto GE, Ashraf GM, Meshref M, Bahbah EI. Neural Stem Cell-Based Therapies and Glioblastoma Management: Current Evidence and Clinical Challenges. Int J Mol Sci 2021;22:2258. [PMID: 33668356 DOI: 10.3390/ijms22052258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang G, Wang W. Advanced Cell Therapies for Glioblastoma. Front Immunol 2022;13:904133. [DOI: 10.3389/fimmu.2022.904133] [Reference Citation Analysis]
2 Ouerdane Y, Hassaballah MY, Nagah A, Ibrahim TM, Mohamed HAH, El-baz A, Attia MS. Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications. Pharmaceuticals 2022;15:76. [DOI: 10.3390/ph15010076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ciftci HI, Radwan MO, Sever B, Hamdy AK, Emirdağ S, Ulusoy NG, Sozer E, Can M, Yayli N, Araki N, Tateishi H, Otsuka M, Fujita M, Altintop MD. EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy. Int J Mol Sci 2021;22:10945. [PMID: 34681605 DOI: 10.3390/ijms222010945] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
4 Mendanha D, Vieira de Castro J, Ferreira H, Neves NM. Biomimetic and cell-based nanocarriers - New strategies for brain tumor targeting. J Control Release 2021;337:482-93. [PMID: 34352316 DOI: 10.1016/j.jconrel.2021.07.047] [Reference Citation Analysis]